RBR-8nkhhk尚未招募未知
Safety and immunogenicity in intramuscular injection of vaccine without aspiration prior to injection: a randomized clinical trial
niversidade Federal de Alagoas - UFA0 个研究点开始时间: 2019年9月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 59Y（—）
入选标准
- •Healthy volunteers; both genders; age between 18 and 59 years.
排除标准
- •Individuals with immunosuppressive disease or treatment; acute febrile illness; made use anti-inflammatory drug, analgesic or antipyretic 24 hours before vaccination; history of allergic reaction to any of the components of the Hepatitis A vaccine; pregnant women; history of hepatitis A disease; history of vaccination against Hepatitis A; previous titration of antibodies against the Hepatitis A virus (anti-HAV IgG); persons undergoing blood transfusion or use of blood products in the last 28 days; persons who are unable to respond on their own.
研究者
相似试验
进行中（未招募）
不适用
Safety and immunogenicity of an intramuscular, inactivated, split-virion, pandemic influenza A/H5N1 vaccine in adults and the elderly.EUCTR2006-000477-29-BESanofi Pasteur SA650
进行中（未招募）
1 期
Safety and immunogenicity of an intramuscular, inactivated, split-virion, pandemic influenza A/H5N1 vaccine in adults and the elderly.Vaccination of adults (18-60 years) and elderly (>60 years) with pandemic flu H5N1 vaccine.EUCTR2006-000477-29-GBsanofi pasteur SA600
已完成
2 期
The effect of dexamethasone injection in infants with acute bronchiolitisAcute bronchiolitis.Acute bronchitis, unspecifiedIRCT2014120218974N2Vice chancellor for research, Kermanshah University of Medical Sciences80
已完成
2 期
Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adultsinfantile paralysispolio10047438NL-OMON32437ederlands Vaccin Instituut120
进行中（未招募）
不适用
Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adults - Intradermal injection of reduced dose IPV in adultsEUCTR2009-015175-27-NLetherlands Vaccine Institute